Singapore markets open in 3 hours 40 minutes
Straits Times Index
3,287.75 -5.38 (-0.16%) S&P 500
5,048.42 -23.21 (-0.46%) Dow
38,085.80 -375.12 (-0.98%) Nasdaq
15,611.76 -100.99 (-0.64%) Bitcoin USD
65,032.77 +831.31 (+1.29%) CMC Crypto 200
1,398.50 +15.93 (+1.15%)
Samsung Biologics Co.,Ltd. (207940.KS)
KSE - KSE Delayed price. Currency in KRW
Add to watchlist
At close: 03:30PM KST
Currency in KRW
Valuation measures4
| Market cap (intra-day) | 56.23T |
| Enterprise value | 56.08T |
| Trailing P/E | 65.55 |
| Forward P/E | 65.36 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 15.22 |
| Price/book (mrq) | 5.72 |
| Enterprise value/revenue | 15.18 |
| Enterprise value/EBITDA | 33.16 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.51 |
| 52-week change 3 | 1.54% |
| S&P500 52-week change 3 | 22.64% |
| 52-week high 3 | 880,000.00 |
| 52-week low 3 | 0.00 |
| 50-day moving average 3 | 814,920.00 |
| 200-day moving average 3 | 760,705.00 |
Share statistics
| Avg vol (3-month) 3 | 70.02k |
| Avg vol (10-day) 3 | 44.94k |
| Shares outstanding 5 | 71.17M |
| Implied shares outstanding 6 | 71.99M |
| Float 8 | 17.91M |
| % held by insiders 1 | 74.75% |
| % held by institutions 1 | 14.15% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | N/A |
| Trailing annual dividend yield 3 | N/A |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 23.22% |
| Operating margin (ttm) | 32.60% |
Management effectiveness
| Return on assets (ttm) | 4.27% |
| Return on equity (ttm) | 9.12% |
Income statement
| Revenue (ttm) | 3.69T |
| Revenue per share (ttm) | 51,909.25 |
| Quarterly revenue growth (yoy) | 11.20% |
| Gross profit (ttm) | N/A |
| EBITDA | 1.6T |
| Net income avi to common (ttm) | 857.69B |
| Diluted EPS (ttm) | N/A |
| Quarterly earnings growth (yoy) | -21.40% |
Balance sheet
| Total cash (mrq) | 2.06T |
| Total cash per share (mrq) | 28,890.83 |
| Total debt (mrq) | 1.91T |
| Total debt/equity (mrq) | 19.42% |
| Current ratio (mrq) | 1.33 |
| Book value per share (mrq) | N/A |
Cash flow statement
| Operating cash flow (ttm) | 1.67T |
| Levered free cash flow (ttm) | -446.65B |
© 2024 Yahoo. All rights reserved.